The company says the new system builds on the success of its predecessor, and introduces several new advancements, including: high stability analysis, which provides physicians with an objective method for identifying regions of interest; expanded catheter compatibility, including the ability to analyse signals with the Medtronic sphere-9 mapping and ablation catheter; and integration with the GE HealthCare CardioLab AltiX AI.i recording system.

Volta says the new advancements will allow electrophysiologists to deliver more efficient procedures.

Earlier in 2025, the AF-Xplorer II received CE Mark approval in Europe, and has been adopted in clinical practice, providing experience that will now be extended to U.S. physicians.